ProMIS Neurosciences Inc. (PMN)
CIK 1374339 · all EDGAR filings →
Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 9.0M shares as of Aug 13, 2026 (10-Q). Share count fell from 53.8M to 9.0M between Nov 12, 2025 and Mar 25, 2026, a pattern consistent with a reverse split (roughly 1-for-6); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.
Cash runway
Going-concern warning
auditor flagged substantial doubt
The company itself flagged going-concern doubt in a filing.
Full breakdown: cash runway tool · source filing →
Warrants
| Tranche | Warrants | Exercise price | Term | Notes |
|---|---|---|---|---|
| Common Share Warrant | 6.9M | $14.4 | — | — |
| Warrant Exercise Price Usd14.40 | 6.9M | $14.4 | — | — |
| Warrant Exercise Price Usd31.25 | 1.1M | $31.25 | — | — |
| Warrant Exercise Price Usd43.75 | 449,084 | $43.75 | — | — |
| Warrant Exercise Price Usd50.50 | 314,170 | $50.5 | — | — |
| Warrant Exercise Price Usd62.50 | 314,170 | $62.5 | — | — |
| Pre Funded Warrants | 100,000 | $0.0001 | — | — |
| Warrant Exercise Price Usd0.0001 | 100,000 | $0.0001 | — | — |
| Warrant Exercise Price Usd0.25 | 74,673 | $0.25 | — | — |
| Warrant Exercise Price Usd315.00 | 20,948 | $315 | — | — |
| Warrant Exercise Price Usd187.50 | 13,831 | $187.5 | — | — |
| Warrant Exercise Price Usd240.00 | 5,868 | $240 | — | — |
Tranches exactly as the company dimensioned them in its 10-Q filed Aug 13, 2026 →. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.
Warrants outstanding: 9.3M underlying shares, as reported Jun 30, 2026 (10-Q).
Reported exercise price: $0.01 (aggregate figure as tagged; individual tranches vary).
Rough fully diluted estimate: 18.3M = 9.0M O/S + 9.3M warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.
Convertible notes
No convertible-note facts tagged in the 10-Q filed Aug 13, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.
Fully diluted build-up
Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.
| Shares outstanding | 9.0M | Aug 13, 2026 |
| + Common Share Warrant (if exercised) | 6.9M | Jan 29, 2026 |
| + Warrant Exercise Price Usd14.40 (if exercised) | 6.9M | Jun 30, 2026 |
| + Warrant Exercise Price Usd31.25 (if exercised) | 1.1M | Jun 30, 2026 |
| + Warrant Exercise Price Usd43.75 (if exercised) | 449,084 | Jun 30, 2026 |
| + Warrant Exercise Price Usd50.50 (if exercised) | 314,170 | Jun 30, 2026 |
| + Warrant Exercise Price Usd62.50 (if exercised) | 314,170 | Jun 30, 2026 |
| + Pre Funded Warrants (if exercised) | 100,000 | Jan 29, 2026 |
| + Warrant Exercise Price Usd0.0001 (if exercised) | 100,000 | Jun 30, 2026 |
| + Warrant Exercise Price Usd0.25 (if exercised) | 74,673 | Jun 30, 2026 |
| + Warrant Exercise Price Usd315.00 (if exercised) | 20,948 | Jun 30, 2026 |
| + Warrant Exercise Price Usd187.50 (if exercised) | 13,831 | Jun 30, 2026 |
| + Warrant Exercise Price Usd240.00 (if exercised) | 5,868 | Jun 30, 2026 |
| Fully diluted estimate | 25.3M | +182.4% vs O/S |
Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.
Registrations and offerings
Registered offering capacity on live registrations: $468.6Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted
Last 12 months: 1 executed · 3 registered.
Full history and shelf status: offering checker · S-3 shelf checker
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.
Keep going: float checker · offering calendar · short-squeeze screener · full PMN workspace